Assessment of Fatty Acids in Infants' Blood Cells When Consuming Infant Formula Containing Long-Chain Polyunsaturated Fatty Acids

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

86 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-02-28

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare amounts of DHA, ARA, and other fatty acids in the blood cells of infants consuming infant formulas containing differing levels of fatty acids

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo

NCT00342303

Fatty Acid Metabolism

COMPLETED

Essential Fatty Acid Nutrition For 1-2 Yr-Olds

NCT01263912

Infant Nutrition

COMPLETED NA

Effect of Tube Feeding on LCPUFAs Delivery

NCT03459209

Lipid Depletion Human Milk Tube Feeding

COMPLETED

Developmental Effects of Infant Formula Supplemented With LCPUFA

NCT00753818

Cognitive Development Growth

COMPLETED NA

Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants

NCT02092857

Focus: Nutritional Requirements for Infants

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Levels of Fatty Acids in the Blood Cells of Infants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Marketed cow milk-based infant formula containing DHA and ARA

No interventions assigned to this group

Investigational 1

Cow milk-based infant formula with differing level of ARA from Control formula

No interventions assigned to this group

Investigational 2

Cow milk-based infant formula with a differing level of ARA from Control

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton birth
* 12-25 days of age
* Gestational age of 37-42 weeks
* Solely formula fed for at least 24 hours prior to randomization
* Birth weight 2500 g - 4000 g

Exclusion Criteria

* Serious concurrent illness or congenital malformation
* Systemic or congenital infection
* Immunocompromised
* History of intolerance or allergy to cow milk
* Maternal autoimmune disorder
* Participation in another clinical study

Minimum Eligible Age

12 Days

Maximum Eligible Age

25 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes